Conditional Approval: Japan Lowers the Bar for Regenerative Medicine Products

Cell Stem Cell - United States
doi 10.1016/j.stem.2015.03.013
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

First Approval of Regenerative Medical Products Under the PMD Act in Japan

Cell Stem Cell
Molecular MedicineGeneticsCell Biology
2016English

Regenerative Medicine

Cell
BiochemistryGeneticsMolecular Biology
2012English

Difficulties in the Translation of Functionalized Biomaterials Into Regenerative Medicine Clinical Products

Biomaterials
Mechanics of MaterialsBiophysicsBiomaterialsBioengineeringCompositesNanoscienceNanotechnologyCeramics
2011English

Injectable Foams for Regenerative Medicine

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
MedicineBioengineeringNanotechnologyBiomedical EngineeringNanoscience
2013English

Regenerative Medicine for Cardiovascular Diseases

Journal of Nihon University Medical Association
2016English

Regenerative Medicine for Battlefield Injuries

2013English

The Reality of Regenerative Medicine for the Kidney

Kitakanto Medical Journal
Medicine
2015English

Regenerative Medicine Manufacturing

Biotechnology Journal
Applied MicrobiologyBiotechnologyMolecular MedicineMedicine
2018English

Regenerative Medicine for Advanced Surgical Care

British Journal of Surgery
Surgery
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy